Community Budget
Issue Requests - Tracking Id #1473FY0001 University Community Hospital Anticoagulation Clinic |
|||||||||
|
|
|
|
|
|
|
|
|
|
Requester: |
Sara Hein |
Organization: |
University Community Hospital |
||||||
|
|
|
|
|
|
|
|
|
|
Project Title: |
University Community Hospital Anticoagulation Clinic |
Date Submitted: |
2/9/01 4:16:41 PM |
||||||
|
|
|
|
|
|
|
|
|
|
Sponsors: |
Johnnie Byrd |
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
Statewide Interest: |
The mission of the clinic is to provide safe anticoagulant drug therapy for outpatients. |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
Recipient: |
University Community Hospital |
Contact: |
Sarah Hein |
||||||
|
3100 E Fletcher Avenue |
Contact Phone: |
(813) 615-7399 |
||||||
|
|
Tampa 33606 |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
Counties: |
Hillsborough |
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
Service Area: |
Private Organization |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
Project Description: |
|
|
|
|
|
|
|
||
Atrial fibrillation (AF) is one of the more common irregular heart rhythms. The highest prevalence of AF is found in the elderly population, a key patient group for the Tampa Bay area. With AF, blood does not move as quickly through the heart, which can result in clot formation in the chambers of the heart. These clots can travel from the heart to the brain, and cause strokes. The risk of stroke in AF is up to five times higher than with normal heart rhythms. As many as 36% of strokes in patients older than 80 years of age are due to AF. The use of the blood-thinning agent warfarin (Coumadin) prevents these clots from forming in the heart. But thinning the blood comes with increased risk for bleeding episodes; anywhere from 6 - 39% of patients have a bleeding episode with long term therapy. This is why as many as half of all AF patients that should receive warfarin therapy do not. Research shows thst the annual risk of stroke in elderly AF patients can be decreased 60 - 80% with a well-mangaged anticoagulant (blood thinning) monitoring clinic. Significant, major, and fatal bleeding episodes can be decreased dramatically. Emergency Department visits for these patients can decrease by 75%. Health care costs are reduced. Most importantly, physicians have been shown to prescribe this therapy more often when they know the AF patient's therapy will be closely monitored. |
|||||||||
|
|||||||||
|
|
|
|
|
|
|
|
|
|
Measurable Outcome Anticipated: |
|
|
|
|
|
||||
Decreased bleeding episodes in patients on anticoagulant (blood-thinning) therapy. Increased use of anticoagulant therapy in AF patients upon discharge. |
|||||||||
|
|
|
|
|
|
|
|
|
|
Amount requested from the State for this project this year: |
$118,690 |
||||||||
|
|
|
|
|
|
|
|
|
|
Identify item(s) in the Appropriations Bill to be reduced: |
|
|
|
|
|||||
Specific Appropriation #: |
|
|
|
|
|
||||
Specific Appropriation Title: |
|
|
|
||||||
Amount to be reduced: |
$ |
|
|
|
|
||||
Fund Source: |
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
Total cost of the project: |
$118,690 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
Request has been made to fund: |
Operations |
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
Type of funding match: |
None |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
Was this project previously funded by the State? |
|
No |
|
||||||
|
|
|
|
|
|
|
|
|
|
Is future-year funding likely to be requested? |
|
Yes |
|
||||||
|
Amount: |
$104,396 |
|
|
|
|
|
||
|
Purpose for future year funding: |
|
Recurring Operations |
|
|||||
|
Will this be an annual request? |
|
|
Yes |
|
|
|||
|
|
|
|
|
|
|
|
|
|
Was this project included in an Agency's Budget Request? |
|
No |
|
||||||
Was this project included in the Governor's Recommended Budget? |
No |
|
|||||||
|
|
|
|
|
|
|
|
|
|
Is there a documented need for this project? |
|
Yes |
|
||||||
|
Documentation: |
FMQAI, June 1995: Pilot study at two hospitals showed that only 50% of AF pt received anticoagulants |
|||||||
|
|
|
|
|
|
|
|
|
|
Was this project request heard before a publicly noticed meeting of a body of elected officials (municipal, county, or state)? |
No |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|